See if an eHealth promotor outreach helps Hispanic women catch up on cervical cancer screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial uses a two-arm cluster randomized design to enroll 160 Hispanic women aged 21-65 who are not up-to-date with cervical cancer screening. One arm receives an educational session delivered by a promotor(a) via eHealth tools, along with a resource list for screening sites; the control arm receives a nutrition-focused education session. The primary outcome is whether participants obtain cervical cancer screening after the intervention. Secondary aims include changes in knowledge and screening-related behaviors. The study is conducted at Florida A&M University with support from NIMHD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. between the age of 21 and 65 years
2. identify as Hispanic
3. not up-to-date with cervical cancer screening \[never screened or last Pap test ≥ 3 years - based on U.S. Preventive Services Task Force guidelines\]
4. have no history of cervical cancer
5. have not had a hysterectomy.

Exclusion Criteria:

1. under the age of 21 or over the age of 65 years
2. do not identify as Hispanic
3. up-to-date with cervical cancer screening \[last Pap test \< 3 years - based on U.S. Preventive Services Task Force guidelines\]
4. history of cervical cancer
5. have had a hysterectomy.

Where it's running

• Florida A&M University
  Tallahassee, Florida, United States Recruiting

Study contacts

• Study coordinator: Professor
• Email: tanise.jackson@famu.edu
• Phone: 8505993214

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of cervical cancer after HPV detection in healthy women

  This study tests how likely it is for cervical cancer to develop after different HPV detection patterns in healthy women who undergo HPV-based screening.

  Recruiting Karolinska Institutet · Stockholm · NCT07850128

• Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier

  Researchers test whether analyzing DNA from cervical smears with shallow whole-genome sequencing can help detect high-grade serous ovarian cancer early in patients undergoing treatment for this cancer.

  Recruiting Institut Claudius Regaud · Toulouse · NCT07821879

• HPV self-sampling in the ED to screen under-screened women

  This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT07657104

• Low-cost HPV test that gives same-day results and treatment in women 30-59

  A low-cost HPV test done on the same day as a self-collected sample is being tested to see if it can reliably screen for cervical cancer and enable immediate treatment in women aged 30-59 in San Salvador.

  Recruiting The Cleveland Clinic · San Salvador, Oriente · NCT07538050

• Self-sampling HPV screening offered in the emergency department

  This project tests whether offering HPV self-sampling in the emergency department helps more people aged 30–65 with a cervix get screened for cervical cancer.

  Recruiting University of Rochester · Rochester, New York · NCT07345897

• Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers

  This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.

  Recruiting at 2 sites Tata Memorial Hospital · Mumbai, Maharashtra and 1 other locations · NCT07290972

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.